Karyopharm Therapeutics Inc. (51) | Business Finance (5)
Browse by Subcategory
Recent Contracts
-
Amendment to Asset Purchase Agreement, dated as of July 17, 2019, by and between the Registrant and Biogen MA Inc
(Filed With SEC on November 3, 2021)
-
Form of Nonstatutory Stock Option Agreement for Inducement Grants adopted August 25, 2020
(Filed With SEC on November 2, 2020)
-
Underwriting Agreement, dated March 3, 2020, by and among the Company, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Jefferies LLC
(Filed With SEC on March 4, 2020)
-
Revenue Interest Financing Agreement, dated September 14, 2019, between the Registrant and HealthCare Royalty Partners III, L.P, and HealthCare Royalty Partners IV, L.P
(Filed With SEC on November 4, 2019)
-
Nonstatutory Stock Option Agreement, dated February 25, 2019, between the Company and Michael Mason
(Filed With SEC on February 25, 2019)